Bioiberica launches Impromune® in Italy for immunocompromised dogs and cats
- It is a complementary food recommended to strengthen the immune system in small pets
- The launch is led by A.T.I.- Azienda Terapeutica Italiana, a division of Fatro Group
Bioiberica Companion Animal Health has announced the launch of Impromune® in Italy, by A.T.I.- Azienda Terapeutica Italiana. This is a complementary food launched in Spain in 2011, which is recommended to strengthen the immune system in dogs and cats with immunosuppression problems.
Impromune® contains Nucleoforce®, a specific nucleotide formula developed following a study of the specific needs of different mammal species. Nucleotides are semi-essential immunonutrients which, freely administered orally, contribute to the proper development of the immune system.
The product also contains AHCC, a mycelial extract of Lentinus edodes, which modulates NK activity, as well as the proliferation of macorphages and differentiation of T lymphocites into Th1 cells. Different studies have shown a synergetic effect of the combination of Nucleoforce® and AHCC in acting on the innate and adaptive immune responses. This synergetic effect has been patented.
A.T.I.- Azienda Terapeutica Italiana, a division of Fatro Group and Bioiberica's distributor in Italy, leads the launch, which is part of the company's international expansion plan for 2020.
Bioiberica is a worldwide leader in the life sciences sector, committed to improving the health and well-being of people, animals and plants. The Companion Animal Health business unit specialises in innovative, science-based solutions to improve the health of chronically ill pets.
Related News
- The product is a supplementary food recommended to nurture growing joints in puppies, principally for fast-growing large breeds and in breeds predisposed to hip dysplasia
- This is the third launch for the joint health area in the last three years, which renews the entire line.
- This dietary supplement is recommended to protect the joints of large dog breeds
- The product stands out for its great palatability, convenient dosage and unique composition on the market
- This completes its Atopivet® range of dermatological products, both orally and topically, which help maintain the skin's integrity and protective barrier
- There is increasing evidence that shows that the epidermal barrier function is impaired in canine atopic dermatitis